Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Price to Cash Earnings (PCE)

    Back to All Ratios
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   PCE(x) 28.35-21.6327.368.439.27

What is the latest Price to Cash Earnings (PCE) ratio of GLENMARK PHARMACEUTICALS ?

The latest Price to Cash Earnings (PCE) ratio of GLENMARK PHARMACEUTICALS is 28.35 based on Mar2025 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar202528.35
Mar2024-21.63
Mar202327.36
Mar20228.43
Mar20219.27

How is Price to Cash Earnings (PCE) of GLENMARK PHARMACEUTICALS Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2025 28.35
Positive
Mar2024 -21.63
Negative
Mar2023 27.36
224.56
Mar2022 8.43
-9.06
Mar2021 9.27 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare Price to Cash Earnings (PCE) ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹64,766.3 Cr 3.7% 6.1% 23.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹468,458.0 Cr 2.8% 7.4% 14.5% Stock Analytics
DIVIS LABORATORIES ₹193,383.0 Cr 6.4% 8.3% 0.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹169,829.0 Cr 2.1% 8.7% 47.7% Stock Analytics
CIPLA ₹116,164.0 Cr 0.5% 3.6% -5.6% Stock Analytics
DR REDDYS LABORATORIES ₹102,648.0 Cr -7.6% -2.2% -5.8% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

3.7%

6.1%

23.6%

SENSEX

0.9%

2.2%

-7.5%


You may also like the below Video Courses